(DSM) BNY Mellon Strategic - Ratings and Ratios
Municipal Bonds, High Yield Securities, Tax Exempt Investments
Description: DSM BNY Mellon Strategic
BNY Mellon Strategic Municipal Bond Fund Inc (NYSE:DSM) is a high-yield municipal bond fund listed on the NYSE, originating from the USA. The funds investment strategy focuses on high-yield municipal bonds, aiming to provide investors with a regular income stream.
To evaluate the funds performance, we can look beyond the provided data. Key Performance Indicators (KPIs) such as the funds yield, duration, and credit quality can offer valuable insights. For instance, a high-yield municipal bond fund like DSM likely has a higher average duration and lower credit quality compared to its peers, which can impact its volatility and potential returns. Investors should also consider the funds expense ratio, dividend coverage, and historical returns relative to its benchmark.
From a technical analysis perspective, the funds price action and trends can be assessed using various indicators. While the provided technical data indicates a relatively stable price, with the last price being $5.64, it is below its 52-week high of $6.13. This suggests that the fund has experienced some volatility over the past year. Further analysis of the funds trading volume, relative strength index (RSI), and moving average convergence divergence (MACD) could provide additional insights into its market dynamics.
To make informed investment decisions, its essential to consider the funds underlying holdings, sector allocation, and geographic distribution. For example, an analysis of the funds top holdings and sector weights can reveal its exposure to specific municipal bond markets, such as revenue bonds or general obligation bonds. This information can help investors assess the funds risk profile and potential for long-term returns.
Additional Sources for DSM Fund
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
DSM Fund Overview
Market Cap in USD | 325m |
Style | High Yield Muni |
TER | 1.28% |
IPO / Inception | 1989-11-22 |
DSM Fund Ratings
Growth Rating | -35.2 |
Fundamental | - |
Dividend Rating | 18.5 |
Rel. Strength | -12.8 |
Analysts | - |
Fair Price Momentum | 5.26 USD |
Fair Price DCF | - |
DSM Dividends
Dividend Yield 12m | 4.00% |
Yield on Cost 5y | 3.74% |
Annual Growth 5y | -9.71% |
Payout Consistency | 92.4% |
Payout Ratio | % |
DSM Growth Ratios
Growth Correlation 3m | 22.4% |
Growth Correlation 12m | -69.5% |
Growth Correlation 5y | -52.8% |
CAGR 5y | -1.71% |
CAGR/Max DD 5y | -0.04 |
Sharpe Ratio 12m | -0.36 |
Alpha | -7.15 |
Beta | 0.071 |
Volatility | 11.62% |
Current Volume | 121.8k |
Average Volume 20d | 120.8k |
Stop Loss | 5.4 (-2.5%) |
As of July 17, 2025, the stock is trading at USD 5.54 with a total of 121,834 shares traded.
Over the past week, the price has changed by -1.72%, over one month by -0.13%, over three months by +2.25% and over the past year by -2.40%.
Probably not. Based on ValueRay´s Analyses, BNY Mellon Strategic (NYSE:DSM) is currently (July 2025) not a good stock to buy. It has a ValueRay Growth Rating of -35.16 and therefor a somwhat technical negative rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DSM is around 5.26 USD . This means that DSM is currently overvalued and has a potential downside of -5.05%.
BNY Mellon Strategic has no consensus analysts rating.
According to our own proprietary Forecast Model, DSM BNY Mellon Strategic will be worth about 5.7 in July 2026. The stock is currently trading at 5.54. This means that the stock has a potential upside of +2.71%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 5.7 | 2.7% |